Morphine and immunosuppression in the context of tumor growth and metastasis

Lisa Koodie, Sabita Roy

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Morphine has been recognized as a highly potent analgesic agent used in cancer and non-cancer (neuropathic, surgical) pain management. Cancer patients may be prescribed morphine at different stages of the disease, during neoplastic growth and progression, during surgical resection and even in end stage palliative care. Morphine has been shown to suppress immune cell activation, ­functionality and cytokine secretion. While the initial infiltration of immune cells during tumor growth can be beneficial in destroying stressed tumor cells, ­prolonged accumulation results in a dampened immune response, enhanced angiogenesis, tumor growth and thus metastasis. The aim of this chapter is summarize the ­immunosuppressive effects of morphine as it relates to metastasis. We describe the effects of morphine as it pertains to tumor cell proliferation and growth, immune cell contribution to angiogenesis and extracellular matrix remodeling within the tumor microenvironment.

Original languageEnglish (US)
Title of host publicationMorphine and Metastasis
PublisherSpringer Netherlands
Pages31-46
Number of pages16
ISBN (Electronic)9789400756786
ISBN (Print)9789400756779
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Immunosuppression
Morphine
Neoplasm Metastasis
Growth
Neoplasms
Tumor Microenvironment
Neuralgia
Pain Management
Immunosuppressive Agents
Palliative Care
Extracellular Matrix
Analgesics
Cell Proliferation
Cytokines

Keywords

  • Immunosuppression
  • Macrophages
  • Mast cells
  • Morphine
  • Myeloid suppressor cells
  • Natural killer cells
  • Neutrophils
  • T cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Morphine and immunosuppression in the context of tumor growth and metastasis. / Koodie, Lisa; Roy, Sabita.

Morphine and Metastasis. Springer Netherlands, 2013. p. 31-46.

Research output: Chapter in Book/Report/Conference proceedingChapter

Koodie, Lisa ; Roy, Sabita. / Morphine and immunosuppression in the context of tumor growth and metastasis. Morphine and Metastasis. Springer Netherlands, 2013. pp. 31-46
@inbook{46f13bc2eb7f40978fe7cec0bd4a6ab0,
title = "Morphine and immunosuppression in the context of tumor growth and metastasis",
abstract = "Morphine has been recognized as a highly potent analgesic agent used in cancer and non-cancer (neuropathic, surgical) pain management. Cancer patients may be prescribed morphine at different stages of the disease, during neoplastic growth and progression, during surgical resection and even in end stage palliative care. Morphine has been shown to suppress immune cell activation, ­functionality and cytokine secretion. While the initial infiltration of immune cells during tumor growth can be beneficial in destroying stressed tumor cells, ­prolonged accumulation results in a dampened immune response, enhanced angiogenesis, tumor growth and thus metastasis. The aim of this chapter is summarize the ­immunosuppressive effects of morphine as it relates to metastasis. We describe the effects of morphine as it pertains to tumor cell proliferation and growth, immune cell contribution to angiogenesis and extracellular matrix remodeling within the tumor microenvironment.",
keywords = "Immunosuppression, Macrophages, Mast cells, Morphine, Myeloid suppressor cells, Natural killer cells, Neutrophils, T cells",
author = "Lisa Koodie and Sabita Roy",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-94-007-5678-6_3",
language = "English (US)",
isbn = "9789400756779",
pages = "31--46",
booktitle = "Morphine and Metastasis",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Morphine and immunosuppression in the context of tumor growth and metastasis

AU - Koodie, Lisa

AU - Roy, Sabita

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Morphine has been recognized as a highly potent analgesic agent used in cancer and non-cancer (neuropathic, surgical) pain management. Cancer patients may be prescribed morphine at different stages of the disease, during neoplastic growth and progression, during surgical resection and even in end stage palliative care. Morphine has been shown to suppress immune cell activation, ­functionality and cytokine secretion. While the initial infiltration of immune cells during tumor growth can be beneficial in destroying stressed tumor cells, ­prolonged accumulation results in a dampened immune response, enhanced angiogenesis, tumor growth and thus metastasis. The aim of this chapter is summarize the ­immunosuppressive effects of morphine as it relates to metastasis. We describe the effects of morphine as it pertains to tumor cell proliferation and growth, immune cell contribution to angiogenesis and extracellular matrix remodeling within the tumor microenvironment.

AB - Morphine has been recognized as a highly potent analgesic agent used in cancer and non-cancer (neuropathic, surgical) pain management. Cancer patients may be prescribed morphine at different stages of the disease, during neoplastic growth and progression, during surgical resection and even in end stage palliative care. Morphine has been shown to suppress immune cell activation, ­functionality and cytokine secretion. While the initial infiltration of immune cells during tumor growth can be beneficial in destroying stressed tumor cells, ­prolonged accumulation results in a dampened immune response, enhanced angiogenesis, tumor growth and thus metastasis. The aim of this chapter is summarize the ­immunosuppressive effects of morphine as it relates to metastasis. We describe the effects of morphine as it pertains to tumor cell proliferation and growth, immune cell contribution to angiogenesis and extracellular matrix remodeling within the tumor microenvironment.

KW - Immunosuppression

KW - Macrophages

KW - Mast cells

KW - Morphine

KW - Myeloid suppressor cells

KW - Natural killer cells

KW - Neutrophils

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84903708214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903708214&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-5678-6_3

DO - 10.1007/978-94-007-5678-6_3

M3 - Chapter

SN - 9789400756779

SP - 31

EP - 46

BT - Morphine and Metastasis

PB - Springer Netherlands

ER -